卵巢低反应预测指标及治疗方法的研究进展

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (0 KB) HTML (51 KB)
输出: BibTeX | EndNote (RIS)

摘要卵巢反应性是指在促排卵过程中，卵巢对外源性促性腺激素的反应并使卵泡发育的能力。有研究显示，在促排卵治疗中，卵巢低反应的发生率约为20%。有众多的因素影响卵巢反应性，如年龄、窦卵泡数、基础激素水平、AMH、卵巢基质血流等。针对影响卵巢低反应患者的治疗方法很多，但临床效果不佳，本文对卵巢低反应的检测指标及治疗方法进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘艳美

关键词 ：卵巢低反应, 检测指标, 治疗

Abstract：Ovarian response refers to the ability of ovaries responding to exogenous gonadotropins and to develop follicles during ovulation induction.Studies have shown that the incidence of poor ovarian response is about 20%in ovulation induction.There are many factors influencing on ovarian response including age,number of antral follicles,basal hormone levels,anti-mullerian hormone (AMH),and ovarian stromal flow,etc..In patients with poor ovarian response,many therapeutic methods can be used,but with an unfavorable effect.This paper reviewed the predictive index and treatment methods of poor ovarian response.

Key words： Poor ovarian response Predictive index Treatment

引用本文:

刘艳美. 卵巢低反应预测指标及治疗方法的研究进展[J]. 中国当代医药, 2017, 24(11): 21-24.
LIU Yan-mei. Research progress of predictive index of poor ovarian response and therapeutic methods. 中国当代医药, 2017, 24(11): 21-24.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2017/V24/I11/21

[4]	罗爱月，杨书红，王世宣.卵巢衰老的研究进展[J].实用医学杂志，2011，27（20）：3800-3802.
[5]	杨瑶，张平，刘红.腹腔镜双侧卵巢子宫内膜异位囊肿剔除术对卵巢储备功能及生育的影响[J].中国妇幼保健，2015，30（13）：2116-2117.
[1]	Ubaldi FM，Rienzi L，Ferrero S，et al.Management of poor responders in IVF[J].Reprod Biomed Online，2005，10（2）：235-246.
[2]	Jiao X，Qin C，Li J，et al.Cytogenetic analysis of 531 Chinese women with premature ovarian failure[J].Hum Reprod（Oxford England），2012，27（7）：2201-2207.
[3]	Muasher SJ.Controversies in assisted reproduction：treatment of low responders[J].J Assisted Reprod Genet，1993，10（1）：112-114.
[6]	Pigny P，Jonard S，Robert Y，et al.Serum anti-Müllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome[J].J Clin Endocrinol Metab，2006，91（3）：941-945.
[7]	Fanchin R，Taieb J，Lozano DH，et al.High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in theassessment of ovarian follicular status[J].Hum Reprod，2005，20（4）：923-927.
[8]	Evers JL，Slaats P，Land JA，et al.Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization[J].Fertil Steril，1998，69（4）：1010-1014.
[9]	Broekmans FJ，Kwee J，Hendriks DJ，et al.A systematic review of tests predicting ovarian reserve and IVF outcome[J]. Hum Reprod Update，2006，12（6）：685-718.
[10]	Nelson SM，Yates RW，Fleming R.Serum anti-Müllerian hormone and FSH：prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy[J].Hum Reprod，2007，22（9）：2414-2421.
[11]	Broer SL，Mol BW，Hendriks D，et al.The role of antimullerian hormone in prediction of outcome after IVF：comparison with the antral follicle count[J].Fertil Steril，2009，91（3）：705-714.
[12]	Griesinger G，Dafopoulos K，Buendgen N，et al.Elimination half-life of anti-Müllerian hormone[J].J Clin Endocrinol Metab，2012，97（6）：2160-2163.
[13]	Tal R，Tal O，Seifer BJ，et al.Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception：a systematic review and meta-analysis[J].Fertil Steril，2015，103（1）：119-130.
[14]	陈颖，郁琦，张以文，等.血清抑制素水平在体外受精—胚胎移植超排卵周期中预测卵巢反应性的价值[J].中华妇产科杂志，2006，41（6）：368-371.
[15]	McIlveen M，Skull JD，Ledger WL.Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a highrisk IVF population[J].Hum Reprod，2007，22（3）：778-785.
[16]	武学清，孔蕊，田莉，等.卵巢低反应专家共识[J].生殖与避孕，2015，35（2）：71-79.
[17]	Hendriks DJ，Mol BW，Bancsi LF，et al.The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization：a systematic review[J].Fertil Steril，2006，86（4）：807-818.
[18]	Lainas TG，Sfontouris IA，Zorzovilis IZ，et al.Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF：a prospective randomised controlled trial（RCT）[J].Hum Reprod，2010，25（3）：683-689.
[19]	Tsui KH，Lin LT，Horng HC，et al.Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation [J].Taiwan J Obstet Gynecol，2014，53（4）：559-565.
[20]	Kaplan SA，Cohen P.The somatomedin hypothesis 2007：50 years later[J].J Clin Endocrinol Metab，2007，92（12）：4529-4535.
[25]	李巍巍，安丽红，张歌，等.芬吗通联合坤泰胶囊在体外受精-胚胎移植卵巢低反应患者中的应用[J].实用医学杂志，2014，30（14）：2308-2310.
[21]	Gutiérrez-Pascual E，Martínez-Fuentes AJ，Pinilla L，et al.Direct pituitary effects of kisspeptin：activation of gonadotrophs and somatotrophs and stimulation of luteinising hormone and growth hormone secretion[J].J Neuroendocrinol，2007，19（7）：521-530.
[22]	Yovich JL，Stanger JD.Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF[J].Reprod Biomed Online，2010，21（1）：37-49.
[23]	Kolibianakis EM，Venetis CA，Diedrich K，et al.Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization：a systematic review and meta-analysis[J].Hum Reprod Update，2009，15（6）：613-622.
[24]	Eftekhar M，Aflatoonian A，Mohammadian F，et al.Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology[J]. Arch Gynecol Obstet，2013，287（5）：1017-1021.
[26]	Tarlatzis BC，Zepiridis L，Grimbizis G，et al.Clinical management of low ovarian response to stimulation for IVF：a systematic review[J].Hum Reprod Update，2003，9（1）：61-76.
[27]	Jayaprakasan K，Campbell B，Hopkisson J，et al.A prospective，comparative analysis of anti-Müllerian hormone，inhibin-B，and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation[J].Fertil Steril，2010，93（3）：855-864.